FDA Inspection 611676 — CorePharma, LLC

CorePharma, LLC — FEI 3002535019

The FDA completed an inspection of CorePharma, LLC on Sep 14, 2009 in Middlesex, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 2 citations were issued during this inspection. Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Sep 14, 2009
Fiscal Year
2009
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Middlesex, NJ (United States)

Additional details

Postmarket Adverse Drug Experience (PADE)

Citations

IDCFRDescription
682321 CFR 314.80(c)Failure by applicant to report ADE
682921 CFR 314.80(c)(2)Failure to report non-alert ADEs

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.